Detalhe da pesquisa
1.
Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
JAMA Oncol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780927